The formation of ESMI Study Groups is a bottom-up initiative. Currently, 10 Groups are active, all led by dedicated members, and closely connected with one another. Together, Study Group members explore a specific theme of shared interest – be part of it!
Study Group News
HYPER-MRI: Open Call for Authors/Contributors | Towards a community-driven Consensus Paper
Next Study Group Webinar 
Jointly organized by the Onco-Immunology and Chemistry Study Groups.
T Cells: Chemistry Meets Therapy
Date:
17 December 2025
15:00-16:00 CET
Speaker 1:
Stephan Fricke, Leipzig
“T cell therapies – Clinical stage of the art and current challenges.”
Speaker 2:
Daniëlle Vugts, Amsterdam
“Radiolabeling T cells for in vivo cell tracking.”
Chairs:
Kristina Djanashvili, Delft / Andreas Maurer, Leipzig / Sandra Heskamp, Nijmegen /Timo De Groof, Brussels
Organiser:
This seminar is chaired and organised jointly by the Chemistry and Onco-Immunology Study Groups
Stephan Fricke is Head of the Department of Cell and Gene Therapy Development at the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig, where his work focuses on the development and clinical application of Advanced Therapy Medicinal Products (ATMPs).
Daniëlle Vugts is Associate Professor at the Amsterdam VU University Medical Centre. She has a PhD in organic chemistry and over 12 years’ experience in radiochemisty.
Membership
Currently there are ten active Study Groups – all strongly connected. Membership in any Study Group is free of additional charge for members of the society.
Interested in joining a Study Group?
You are an ESMI member already? Just log-in to your ESMI member portal, proceed to “Profile” and sign-in to any Study Group you are interested in.
Not a member yet?
Proceed to the Member Portal and register – it is just 85€/year, 20€/year for PhD students.